Increased immunity and BRAF inhibition: Yet another argument for combination therapy?

被引：1
|
作者：
Smalley, Keiran S. M. [1 ,2 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, 12902 Magnolia Dr, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA
来源：
PHARMACOLOGICAL RESEARCH | 2016年 / 113卷
关键词：
UNTREATED MELANOMA; VEMURAFENIB; IPILIMUMAB; EXPRESSION; NIVOLUMAB; TUMOR;
D O I：
10.1016/j.phrs.2016.06.015
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：719 / 720
页数：2
相关论文
共 50 条
  • [31] BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes
    Cooper, Zachary A.
    Frederick, Dennie T.
    Juneja, Vikram R.
    Sullivan, Ryan J.
    Lawrence, Donald P.
    Piris, Adriano
    Sharpe, Arlene H.
    Fisher, David E.
    Flaherty, Keith T.
    Wargo, Jennifer A.
    [J]. ONCOIMMUNOLOGY, 2013, 2 (10):
  • [32] Intensifying tumour immunity through combination therapy
    Dranoff, Glenn
    [J]. LANCET ONCOLOGY, 2012, 13 (05): : 440 - 442
  • [33] Neuropathy increased with combination HIV therapy
    [J]. Reactions Weekly, 2000, 802 (1) : 4 - 4
  • [34] A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis
    Mazloumi, Zeinab
    Rafat, Ali
    Asl, Khadijeh Dizaji
    Charoudeh, Hojjatollah Nozad
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 640 : 50 - 55
  • [35] STARTING ANTIHYPERTENSIVE TREATMENT WITH COMBINATION THERAPY: CON SIDE OF THE ARGUMENT
    Staessen, Jan A.
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 : E12 - E12
  • [36] FGFR inhibition re-sensitizes BRAF/MEK dual resistant cells to the BRAF/MEK inhibitor combination
    Wang, Victoria E.
    Settleman, Jeffrey
    McCormic, Frank
    [J]. CANCER RESEARCH, 2017, 77
  • [37] Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade ganglioglioma
    Yau, Wing Hing
    Ameratunga, Malaka
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (05) : 1172 - 1174
  • [38] SAFE CELL AND GENE THERAPY COMBINATION: ARE WE THERE YET IN ARTHRITIS?
    Nagy, A.
    Neely, E. J.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S16 - S16
  • [39] Autophagy inhibition reverses resistance to targeted BRAF therapy in CNS
    Zahedi, Shadi
    Griesinger, Andrea M.
    Hankinson, Todd C.
    Handler, Michael H.
    Foreman, Nicholas K.
    Thorburn, Andrew
    Levy, Jean M. Mulcahy
    [J]. CANCER RESEARCH, 2015, 75
  • [40] BRAF Inhibition: Bridge or Boost to T-cell Therapy?
    Goff, Stephanie L.
    Rosenberg, Steven A.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2682 - 2684
12345